1-3 of 3
Vandana Gupta
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract GS1-01: Tucatinib vs placebo, both combined with capecitabine and trastuzumab, for patients with pretreated HER2-positive metastatic breast cancer with and without brain metastases (HER2CLIMB)

Rashmi Murthy, Sherene Loi, Alicia Okines, Elisavet Paplomata, Erika Hamilton, Sara Hurvitz, Nancy Lin, Virginia Borges, Vandana Gupta Abramson, Carey Anders, Philippe L Bedard, Mafalda Oliveira, Erik Jakobsen, Thomas Bachelot, Shlomit S Shachar, Volkmar Mueller, Sofia Braga, Francois P Duhoux, Richard Greil, David Cameron, Lisa Carey, Giuseppe Curigliano, Karen Gelmon, Gabriel Hortobagyi, Ian Krop, Sibylle Loibl, Mark Pegram, Dennis Slamon, Maria Corinna Palanca-Wessels, Luke Walker, Wentao Feng, Eric Winer
Journal: Cancer Research
Cancer Res (2020) 80 (4_Supplement): GS1-01.
DOI: https://doi.org/10.1158/1538-7445.SABCS19-GS1-01
Published: 15 February 2020
View article
Journal Articles

Mullerian-Inhibiting Substance Induces Gro-β Expression in Breast Cancer Cells through a Nuclear Factor-κB–Dependent and Smad1-Dependent Mechanism

Vandana Gupta, Giminna Yeo, Hirofumi Kawakubo, Vivek Rangnekar, Preethi Ramaswamy, Tetsu Hayashida, David T. MacLaughlin, Patricia K. Donahoe, Shyamala Maheswaran
Journal: Cancer Research
Cancer Res (2007) 67 (6): 2747–2756.
DOI: https://doi.org/10.1158/0008-5472.CAN-06-2312
Published: 15 March 2007
View article
PDF
Journal Articles

MIS promotes IFN-beta induced IRF-1 expression and suppression of breast cancer cell growth

Vandana Gupta, Patricia Donahoe, Shyamala Maheswaran
Journal: Cancer Research
Cancer Res (2004) 64 (7_Supplement): 1223.
Published: 01 April 2004
View article